MK-458, A SELECTIVE AND POTENT D2 RECEPTOR AGONIST IN ADVANCED PARKINSONS-DISEASE

被引:9
|
作者
LIEBERMAN, A [1 ]
CHIN, L [1 ]
BAUMANN, G [1 ]
机构
[1] NEW YORK INFIRM BEEKMAN DOWNTOWN MED CTR,DEPT SURG,NEW YORK,NY
关键词
D O I
10.1097/00002826-198806000-00001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:191 / 200
页数:10
相关论文
共 50 条
  • [41] 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils
    Monneret, G
    Cossette, C
    Gravel, S
    Rokach, J
    Powell, WS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (01): : 349 - 355
  • [42] NMDA RECEPTOR INVOLVEMENT IN 2 ANIMAL-MODELS OF PARKINSONS-DISEASE
    ZEEVALK, GD
    NICKLAS, WJ
    SONSALLA, PK
    NEUROBIOLOGY OF AGING, 1994, 15 (02) : 269 - 270
  • [43] BETA(2) ADRENERGIC AGONIST AS ADJUNCT THERAPY TO L-DOPA IN PARKINSONS-DISEASE
    ALEXANDER, GM
    SCHWARTZMAN, RJ
    NUKES, TA
    GROTHUSEN, JR
    NEUROLOGY, 1993, 43 (04) : A349 - A349
  • [44] Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist
    Xu, Jinbin
    Vangveravong, Suwanna
    Li, Shihong
    Fan, Jinda
    Jones, Lynne A.
    Cui, Jinquan
    Wang, Ruike
    Tu, Zhude
    Chu, Wenhua
    Perlmutter, Joel S.
    Mach, Robert H.
    NEUROIMAGE, 2013, 71 : 168 - 174
  • [45] DOPAMINE-D2 RECEPTOR DENSITY IS INVERSELY CORRELATED WITH DOPAMINERGIC INNERVATION IN UNTREATED PARKINSONS-DISEASE
    SNOW, B
    BUCKLEY, K
    BAILEY, D
    ADAM, M
    CALNE, D
    COOPER, S
    DOBKO, T
    JIVAN, S
    MORRISON, K
    RUTH, T
    SCHOFIELD, C
    SOSSI, V
    NEUROLOGY, 1993, 43 (04) : A269 - A269
  • [46] A POTENT AND SELECTIVE AGONIST FOR NK-2 TACHYKININ RECEPTOR
    ROVERO, P
    PESTELLINI, V
    PATACCHINI, R
    GIULIANI, S
    SANTICIOLI, P
    MAGGI, CA
    MELI, A
    GIACHETTI, A
    PEPTIDES, 1989, 10 (03) : 593 - 595
  • [47] Development of a Bivalent Dopamine D2 Receptor Agonist
    Kuehhorn, Julia
    Goetz, Angela
    Huebner, Harald
    Thompson, Dawn
    Whistler, Jennifer
    Gmeiner, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (22) : 7911 - 7919
  • [48] PET evaluation of the dopamine D2 receptor agonist
    Finnem, SJ
    Seneca, N
    Gulyas, B
    Sovago, J
    Farde, L
    Innis, RB
    Wikstrom, HV
    Halldin, C
    NEUROIMAGE, 2004, 22 : T175 - T175
  • [49] Δ12-Prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes
    Gazi, L
    Gyles, S
    Rose, J
    Lees, S
    Allan, C
    Xue, LZ
    Jassal, R
    Speight, G
    Gamble, V
    Pettipher, R
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2005, 75 (1-4): : 153 - 167
  • [50] NEUROPEPTIDES, EXCITATORY AMINO-ACID AND ADENOSINE A2 RECEPTORS REGULATE D2 RECEPTORS VIA INTRAMEMBRANE RECEPTOR-RECEPTOR INTERACTIONS - RELEVANCE FOR PARKINSONS-DISEASE AND SCHIZOPHRENIA
    FUXE, K
    AGNATI, LF
    VONEULER, G
    TANGANELLI, S
    OCONNOR, WT
    FERRE, S
    HEDLUND, P
    ZOLI, M
    NEUROCHEMISTRY INTERNATIONAL, 1992, 20 : S215 - S224